BioSpace News Archive

The CATS®-D Disposable Prism, designed to deliver improved intraocular pressure (IOP) measurement accuracy using a sterile, disposable tip replacement for the Goldmann Tonometer, received FDA clearance and will be available for sale fall 2021.

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announced the appointment of Jay Sial as its Chief Administrative Officer, effective July 15, 2021.

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced that the company has expanded patient enrollment to Canada for the final part of a Phase 2b study evaluating its EB01 drug candidate as a monotherapy for chronic Allergic Contact Dermatitis, or ACD.

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present “Rebalancing: Digital Therapeutics in a Post-Pandemic Healthcare System” during the virtual conference DTx Europe on July 14th at 5:55 a.m. EST.

Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces an expert analysis titled, “Anemia and Heart Failure: Guidance for Clinicians and Trialists’’ published July 6, 2021 in the American College of Cardiology (ACC) online clinical topics section: https://www.acc.org/latest-in-cardiology/articles/2021/07/06/12/18/anemia-and-heart-failure.

Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2021 financial results on Wednesday, August 4 th , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 4 th , at 9:30 a.m. ET.

FlowMetric Life Sciences Inc., a globally recognized life sciences company, announces the launch of VaxEffect™ COVID-19 Vaccine Immune Response Test, a unique and powerful platform exclusively created to quantitatively assess and track, now and over time, an individual’s immune response to any of the COVID-19 vaccines currently available in the United States.

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that the Centers for Medicare and Medicaid Services (CMS) have established a specific C-Code for PEPAXTO®, C9080.

Movantik® included as preferred brand with no restrictions on a National Formulary of one of America’s largest payors as of July 1st 2021

Stryker, one of the world’s leading medical technology companies, has officially introduced the Tornier shoulder arthroplasty portfolio and launched its first new Tornier product, the Perform™ Humeral Stem.